Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. - Wikidata - awgldk - TriplyDB

Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.

Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.

http://www.wikidata.org/entity/Q33375714

about

Gallbladder Cancer in the 21st Century.Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades EGFR expression in gallbladder carcinoma in North America.Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer.A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients.Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.Chemotherapy and targeted therapy for gall bladder cancer.New insights on cholangiocarcinoma.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Current management of gallbladder carcinoma.Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 Chemotherapy for the biliary tract cancers: moving toward improved survival time.Signaling pathways as therapeutic targets in biliary tract cancer.Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer.

P2860

Q26784174-998491F1-DB35-4E1B-AFBD-9E4E634A9334 Q30234532-82257A80-B23A-410C-926B-9F0916EF6DC4 Q30300756-2C5C7C48-EF32-4FBA-B681-2393891D6C23 Q33372792-19FF0FA7-3778-4BF3-AF90-6DEA1AF5FE5A Q33383423-731B0FB5-360D-4100-9FE5-640EBEB7FA4D Q33390747-9A854C79-A5DF-4B1C-8EA4-E2CE097EBE73 Q33391003-37CF0C83-A4CE-4B22-83DA-92C51E5126A5 Q33395417-6E00513F-39E4-48D4-A6CB-CF18BD9748C2 Q33399656-090D00BA-A247-44FA-91E4-F1D82F6DB8D6 Q33620083-7F971D97-CF6F-49A0-820F-137885E8C8DF Q33977171-B3976B73-8384-4D54-90BD-7A84FC53F416 Q34391135-9DF50C5F-40D0-4616-854E-0BDAD7508915 Q34982545-F1BBB0AC-797C-4127-AB78-89FA60622462 Q35583920-2D4E9B97-E73A-428F-957D-67C24FF0780B Q35871195-2439D416-2303-4C6B-80FA-8D0DC74D4E88 Q37347327-13AFA515-5E17-4DEA-8825-CEBEA4C818C0 Q37983498-EF4B92D0-31CA-4DB3-82AD-D03ABEB947FB Q38747573-63A2A986-BB06-400B-9208-CEE624306A2E Q39012507-A7B5D5E7-411C-4073-8AEC-2F4479EDF7BF Q39313846-8CF5C6B1-28B7-423C-829F-DD4FDBF8254E Q40686537-FE169B7E-0E16-48D8-8271-84F7C0BFC235 Q41128514-25E43ABF-DEBA-4E09-AC36-59CC6437115C

P2860

Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.

http://www.wikidata.org/entity/Q33375714

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@ast

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@en

type

label

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@ast

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@en

prefLabel

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@ast

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@en

P1433

Q33375714-93613C07-3C53-4B85-AB2C-193812A6FA85

P1476

Q33375714-1BFBA564-DEAD-403E-989E-ABE53CE1DFE1

P2093

Q33375714-08C4223F-98B9-4F7F-9311-D623D7CE22A0

Q33375714-2D60ED3E-0EA3-4AB5-9CBC-18FDD81933E4

Q33375714-3FD732B9-E205-4768-B1D8-9D3FF79EF0BF

Q33375714-6F7DC97B-76AA-4956-BB38-EE9530EE0C3E

Q33375714-8B56605D-CF3C-423D-8DEC-C6AFA08D22A5

Q33375714-A7FDAAB4-57B1-4A1A-9370-D95DBC6EAA4F

Q33375714-B13DF41F-69C2-426C-BB16-6C65AC95855A

Q33375714-BA90BFE4-C385-4E92-B896-28618C84717C

P2888

Q33375714-D954A065-EF25-4D3D-9A1B-A2CFAA7461C5

P304

Q33375714-415420A8-B47A-4940-B227-1AE4283F7164

P31

Q33375714-F6CCA6CD-B514-4578-8B52-559A56FC6178

P356

Q33375714-57B37F7B-7E14-4EDB-A906-9214A2DCAE5D

P433

Q33375714-AA145B72-C940-45FE-8B39-1A5A6817673D

P478

Q33375714-62B579EB-8F49-4D94-BD58-0CF64FD80E23

P50

Q33375714-3C32D4D7-FCD1-41F6-8B9A-1FF928EF94D7

Q33375714-D2EB5B7A-9BCF-4711-8E07-6CD50B6F3963

P577

Q33375714-5B51540E-5391-44D6-BA90-FB1AF801DC8E

P6179

Q33375714-9B01D756-8D19-4185-834E-C4C540668249

P698

Q33375714-D7130C2F-3974-4066-9693-BAA823D461E8

P356

S10620-007-9885-2

P1433

Digestive Diseases and Sciences

P1476

Phase-II study of gemcitabine ...... iliary and gallbladder cancer.

@en

P2093

Andrew X Zhu

http://www.w3.org/2001/XMLSchema#string

Craig C Earle

http://www.w3.org/2001/XMLSchema#string

David P Ryan

http://www.w3.org/2001/XMLSchema#string

Keith Stuart

http://www.w3.org/2001/XMLSchema#string

Lawrence Blaszkowsky

http://www.w3.org/2001/XMLSchema#string

Matthew H Kulke

http://www.w3.org/2001/XMLSchema#string

Nicole Lehman

http://www.w3.org/2001/XMLSchema#string

Pankaj Bhargava

http://www.w3.org/2001/XMLSchema#string

P2888

s10620-007-9885-2

P304

564-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-007-9885-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Charles S. Fuchs

Jeffrey A Meyerhardt

P577

2007-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009557115

http://www.w3.org/2001/XMLSchema#string

P698

17597402

http://www.w3.org/2001/XMLSchema#string